AI in GxP: governance without giving up control
AI in GxP is not subject to a blanket prohibition; it is a risk-based control task. What matters is a clear intended use, controlled sources and data, appropriate validation and testing, documented human review, change control and an audit trail. EU GMP Annex 22 remains a draft; GAMP 5 already addresses AI/ML explicitly.
Is AI even allowed to work in GxP environments?
The question still comes up in QA meetings — the regulators have established a risk-based frame for it. Across the frameworks considered here, there is no blanket ban on AI in regulated environments. Instead, they define under which conditions AI work is acceptable. Those conditions look alike across all frameworks — risk-based, traceable, with human responsibility.
That shifts the real task. It is not the policy debate that decides whether your company can use AI — it is whether your working environment structurally provides the required controls: source binding, attributable review decisions, complete documentation. A generic chat interface does not provide that. This controlled working environment is what GxP AI software must add to the language model. The concrete document work — understanding, updating and evidencing existing Word documents — is bundled on GxP documents with AI.
The 2026 regulatory frame — four anchors
Four documents currently determine how AI use in GxP environments is assessed:
- EU GMP Annex 22 (draft): the first GMP annex dedicated entirely to artificial intelligence — published for consultation in July 2025, together with the Annex 11 revision. Core points: intended use, validation of static models, human oversight, explainability. Generative AI sits outside the critical scope — in non-critical, supporting applications it remains possible, with documented human review. The details: our Annex 22 analysis; its relation to Annex 11 in Annex 22 vs Annex 11.
- GAMP 5 Second Edition (2022): the industry guide recognises AI/ML as part of computerised systems and puts critical thinking above schematic documentation — what changes is covered in our GAMP 5 article; the practical validation path for models in validating AI systems under GAMP 5.
- FDA Computer Software Assurance: final since September 2025, updated in February 2026 (QMSR terminology). CSA does not prescribe a tool — it requires risk-based testing depth: CSA vs. CSV compared.
- 21 CFR Part 11 / ALCOA+: the constant: electronic records, signatures and tamper-evident audit trails. Every piece of AI-assisted work must meet these requirements in the end — regardless of which tool wrote the draft. What ALCOA+ requires in practice, in ALCOA+ and data integrity.
What stands out is the convergence: four frameworks, one direction — risk-based, source-bound, human-owned. Align your AI work with these three principles and you can answer to all four anchors.
ChatGPT and LLMs for GxP compliance: the model name is not the control
People searching for “ChatGPT in GxP” or an “LLM for GxP compliance” usually ask two questions at once: may a general-purpose language model work on regulated documents, and is an enterprise edition enough to make that acceptable?
The product name answers neither question. GxP suitability depends on the intended use and the controlled process around it. Which data may the system access? Which approved sources support a statement? How is output marked as a draft? Who reviews content and completeness? Which changes and decisions remain traceable later?
Enterprise security, identity and data-processing controls may be important prerequisites. They do not automatically create source binding, professional review or an audit trail on the GxP work object. The reverse is also true: a specialised GxP system does not make a draft correct by itself. It must make the review structurally possible while accountability remains with the regulated company.
A current US enforcement signal makes that distinction concrete. In the FDA warning letter on AI agents, the agency did not focus on a model brand. It focused on unreviewed AI-generated GMP documents and inadequate Quality Unit oversight.
Where AI works well today — and where it doesn't
The honest map, as of 2026:
Sensible today — supporting, document-level work where a human reviews, corrects and decides:
- Document drafting: drafts for URS, specifications, test documentation and SOPs — from controlled sources, with citations. The product page for GxP documents with AI shows how existing Word files return with tracked changes and source comments. The biggest time sink in Computer System Validation is rarely the testing — it is the writing and holding-together.
- Review preparation: finding inconsistencies, gaps and contradictions across document sets before the human review starts.
- Audit preparation: consolidating evidence, building gap lists, drafting answers with source binding — assessment stays with QA (audit readiness).
- Knowledge access: answering questions against your own controlled source space — instead of the open internet.
Not today — and not in the foreseeable future:
- Generative AI in critical GMP applications — the Annex 22 draft does not foresee its use there.
- Autonomous approvals: AI must not approve its own suggestions, technically or formally. Review, decisions and any required signature stay with people in the defined customer process.
- Continuously learning models in validated processes: a state that keeps changing cannot be demonstrated as stable.
This boundary is not a weakness of the technology — it is what makes the sensible part defensible in an inspection.
Five control principles that make AI work defensible
Whether an AI deployment holds up in an inspection is decided by the control architecture. Five principles have proven load-bearing — they are also the foundation of the traqx trust architecture:
- Source binding (citation): every regulatory statement ends on a clickable source from the controlled source space. A statement without a valid controlled source does not pass the source check; missing inputs remain visible as open points.
- Ghost values: an AI suggestion visibly remains a suggestion until a human adopts it. Draft and human-confirmed state can never be confused.
- Human-in-the-loop: review, correction and decisions remain attributable to a person and role. Responsibility cannot be delegated to a model.
- Deterministic checking: whether citations exist and statements match their source is not judged by a second language model but by a deterministic check: pass or fail.
- Complete audit trail: who decided what, when, on what basis — across the whole lifecycle, tamper-evident (21 CFR Part 11, ALCOA+).
The test for any tool — including ours: can these five principles be demonstrated structurally, or do they depend on the discipline of individual users?
Introducing AI in practice: start with one process
The successful AI introductions we see in regulated environments follow the same pattern — and it is the opposite of a major IT project:
- One team, one real process: not the whole organisation, but one bounded GxP process with real pain — an SOP revision, a validation package, an audit preparation.
- Source space first: before the first prompt comes the question of which controlled documents the AI may work from. The source space is the risk boundary.
- Stop/go criteria up front: how will you tell after four to six weeks whether it carries? Review effort, correction reasons, evidence quality — defined before, not interpreted after.
- QA at the table from day one: not as the approval body at the end, but as co-designer of the controls. That changes acceptance fundamentally.
What does not work: the big-bang rollout (“AI for everyone, starting Monday”), shadow use without a source space — and the opposite mistake of waiting two years for the final edition of every guidance while your team is already working unmanaged with public chat tools.
The operating framework for this is a GxP AI policy: it translates governance into permitted use, a simple screening question, data rules, human review and documented stop conditions.
The most common objections — and what sits behind them
“AI hallucinates — we cannot afford that.” Correct: hallucination is a model risk that a controlled architecture must contain. With source binding and deterministic checking, an invented reference fails the deterministic source check before it reaches a review. The danger is not the model — it is uncontrolled use of it.
“Our data must not train a model.” A legitimate requirement — and solvable contractually and technically: EU hosting, no model training on customer data, a defined source space. That belongs in every supplier assessment of an AI vendor.
“Do we have to validate the AI tool itself?” The tool is qualified risk-based like other software (GAMP 5 logic); what matters is that the work products stay evidenced — source, review, decision, audit trail. Responsibility for the content stays with the regulated company.
“What will an auditor say?” Auditors ask the same questions they ask about any work: where does the statement come from, who reviewed and decided, where is the trail? A controlled AI environment answers these questions faster than manual work — because the connection never breaks.
What this means for your roadmap
The regulatory frame is converging, the control principles are known, and the entry can be small. The order we recommend: pick one process, define the source space, set stop/go criteria, bring QA to the table — and assess honestly after a period defined in advance.
That entry is exactly what traqx is built for: AI drafts, your team reviews, corrects and decides — sources, versions and the audit trail stay connected. The fastest way to see how that works on your process is a product demo. For internal preparation, use the 10 controlled GxP AI prompt patterns and the 12 questions for assessing GxP AI. If you first need to clarify the system role, use the GxP AI software comparison.
Frequently asked questions
What does GxP AI governance require?
GxP AI governance connects a clearly defined intended use with risk-based controls across the lifecycle: defined roles, controlled sources and data, documented supplier and model assessment, proportionate validation and testing, change control, performance monitoring, human review and traceable decisions. The exact controls depend on the specific GxP use and its risk.
Is AI allowed in GxP environments?
Yes, provided the use is risk-based, documented traceably and carried under human responsibility. For the frameworks covered here there is no blanket AI ban. What matters is whether your working environment structurally provides the required controls: source binding, attributable review decisions, gap-free documentation.
Which frameworks are relevant for AI in GxP in 2026?
Four assessment anchors, applicable depending on jurisdiction and context: EU GMP Annex 22 (draft July 2025, the first AI-only annex), GAMP 5 Second Edition (which addresses AI/ML explicitly), the FDA Computer Software Assurance (risk-based) and 21 CFR Part 11. Annex 22 and the parallel Annex 11 revision are drafts — the current status is worth tracking.
Can ChatGPT or an LLM be used for GxP compliance?
The product name does not determine GxP suitability. On the Annex 22 draft, generative AI and LLMs should not be used in critical GMP applications — those with a direct impact on patient safety, product quality or data integrity. In non-critical, supporting applications they are not ruled out in principle; qualified staff must review and document the suitability of the output. A generic chat interface does not establish the required controls by itself. Intended use, controlled sources, human review, change control and an audit trail are what matter.
What distinguishes a general LLM from GxP AI software?
A general LLM generates language; GxP AI software must also support the controlled work process. That includes a defined source space, visible draft status, source checks, traceable changes, human decisions and an audit trail. Specialised software still does not replace professional review or the regulated company's responsibility.
What makes AI work in GxP defensible?
The control architecture, not the model: every AI statement needs a controlled basis, every draft stays a proposal until human review, and a gap-free audit trail documents decisions. These principles hold across all frameworks.
Key takeaways
- Across the four anchors considered here there is no blanket AI ban — draft Annex 22, GAMP 5 2nd Ed, FDA CSA and Part 11 define the how: risk-based, source-bound, human-owned.
- Generative AI belongs in supporting, document-level work with human review today — not in critical GMP applications and not in autonomous decisions.
- Defensibility is architecture, not discipline: source binding, ghost values, human-in-the-loop, deterministic checking and the audit trail must be built into the tool structurally.
- The proven entry: one team, one real process, a defined source space, stop/go criteria up front — QA at the table from day one.
- Waiting is the riskiest option: without a controlled environment, shadow AI use emerges — unmanaged and impossible to audit.
Sources
- European Commission — EudraLex Vol. 4, draft Annex 22 “Artificial Intelligence” (consultation July–October 2025) — the first GMP annex on AI: scope, static models, human oversight, explainability.
- ISPE — GAMP 5: A Risk-Based Approach to Compliant GxP Computerized Systems, 2nd Edition (2022) — critical thinking, agile lifecycles and the treatment of AI/ML in the system lifecycle.
- FDA — Computer Software Assurance for Production and Quality Management System Software (final guidance: 24 September 2025, updated 3 February 2026) — risk-based testing depth instead of documentation volume; tool-neutral.
- EU GMP Annex 11 — Computerised Systems (EudraLex Vol. 4) — the general frame for computerised systems that Annex 22 is embedded in.
- 21 CFR Part 11 — Electronic Records; Electronic Signatures — electronic records, signatures and tamper-evident audit trails.